This compound is a dihydrobromide salt form of a piperidinyl-imidazole derivative, utilized as a reference standard for identifying and quantifying impurities in alcaftadine active pharmaceutical ingredient (API) during manufacturing and quality control processes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(1-methylpiperidin-4-yl)(1-phenethyl-1H-imidazol-2-yl)methanone
pharmaceutical raw material
11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepine
pharmaceutical raw material
Alcaftadine carboxylic acid
pharmaceutical raw material
Alcaftadine
pharmaceutical raw material
Rosuvastatin sodium
pharmaceutical raw material
4-[[1-(2-Phenylethyl)-1h-imidazol-2-yl]carbonyl]-1-piperidinecarboxylic acid ethyl ester
pharmaceutical impurity reference standard
[1-(2-phenylethyl)imidazol-2-yl]-piperidin-4-ylmethanone;dihydrobromide
SRAYLNLUNZDJHD-UHFFFAOYSA-N
C1CNCCC1C(=O)C2=NC=CN2CCC3=CC=CC=C3.Br.Br
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.